Treatment for Prostate Cancer
Treatment for Prostate Cancer : Advanced prostate cancer patients’ quality of life is improved by the search and destroy strategy.
Introduction: Treatment for Prostate Cancer
Table of Contents
Patients with advanced prostate cancer have found that the “search and destroy” therapy, a new radioactive drug that targets and eliminates tumour cells, improves their quality of life.
A radioactive chemical is used in the procedure, known as 177Lu-PSMA-617, as a form of targeted therapy to bind to cancer cells. The molecule emits radiation after it has been bound, which destroys the cells.
According to a research that appeared in the journal The Lancet, individuals who got 177Lu-PSMA-617 had much better quality of life than those who received normal care. The research also revealed that the therapy was well-tolerated and had no significant side effects.
Although “search and destroy” therapy is still in its infancy, it offers the potential to provide patients with advanced prostate cancer with a new choice. In other nations, the medication is currently undergoing clinical testing, and it is anticipated that the UK will soon have access to it.
The following are a few advantages of the “search and destroy” method:
- Patients with advanced prostate cancer may experience an improvement in their quality of life.
- It does not have any harmful side effects and is well tolerated.
- It is a targeted therapy, which implies that it spares healthy cells while solely focusing on cancer cells.
- Patients who have improved on other medications may be treated with it.
Conclusion Treatment for Prostate Cancer:
A promising new therapy for advanced prostate cancer is called “search and destroy”. When previous therapies have failed, it may give patients a new option and enhance their quality of life.
